Drug Profile
GX 120
Alternative Names: GX-120Latest Information Update: 02 Aug 2010
Price :
$50
*
At a glance
- Originator Genexine
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 24 Sep 2007 Phase-I/II clinical trials in HIV infections treatment in South Korea (IM)